ArticleMolecular cancer therapeutics2025

TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile.

Annette M Vogl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.